4-1bb Signaling Beyond T Cells

Cellular and Molecular Immunology - United States
doi 10.1038/cmi.2010.82
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

4-1bb Signaling Breaks the Tolerance of Maternal CD8+ T Cells That Are Reactive With Alloantigens

PLoS ONE
Multidisciplinary
2012English

Ex Vivo Expansion of CD4+CD25+FoxP3+ T Regulatory Cells Based on Synergy Between IL-2 and 4-1bb Signaling

Journal of Immunology
AllergyImmunology
2007English

Enhanced CD4 T Cell Responsiveness in the Absence of 4-1bb

Journal of Immunology
AllergyImmunology
2005English

4-1bb Ligand (4-1bbl; TNFSF9; CD137L)

Science-Business eXchange
2012English

Preventing LCK Activation in CAR T Cells Confers Treg Resistance but Requires 4-1bb Signaling for Them to Persist and Treat Solid Tumors in Non-Lymphodepleted Hosts

Clinical Cancer Research
Cancer ResearchOncology
2018English

Serum Concentrations of Soluble 4-1bb and 4-1bb Ligand Correlated With the Disease Severity in Rheumatoid Arthritis

Experimental & Molecular Medicine
2004English

Signaling Microdomains in T Cells

FEBS Letters
GeneticsCell BiologyMolecular BiologyBiochemistryStructural BiologyBiophysics
2010English

4-1bb Ligand Induces Cell Division, Sustains Survival, and Enhances Effector Function of CD4 and CD8 T Cells With Similar Efficacy

Journal of Immunology
AllergyImmunology
2001English

Combination of 4-1bb Agonist and PD-1 Antagonist Promotes Antitumor Effector/Memory CD8 T Cells in a Poorly Immunogenic Tumor Model

Cancer immunology research
Cancer ResearchImmunology
2014English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy